Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS
This study has been completed.
Sponsor:
Rush University Medical Center
Collaborator:
H. Lundbeck A/S
Information provided by:
Rush University Medical Center
ClinicalTrials.gov Identifier:
NCT00467610
First received: April 26, 2007
Last updated: February 4, 2009
Last verified: February 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2009 |
| Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |